vs

Side-by-side financial comparison of Axos Financial, Inc. (AX) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $385.1M, roughly 1.9× Axos Financial, Inc.). Healthpeak Properties runs the higher net margin — 73.2% vs 33.3%, a 39.8% gap on every dollar of revenue. On growth, Axos Financial, Inc. posted the faster year-over-year revenue change (25.1% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $85.4M). Over the past eight quarters, Axos Financial, Inc.'s revenue compounded faster (14.3% CAGR vs 8.9%).

Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

AX vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.9× larger
DOC
$719.4M
$385.1M
AX
Growing faster (revenue YoY)
AX
AX
+22.0% gap
AX
25.1%
3.1%
DOC
Higher net margin
DOC
DOC
39.8% more per $
DOC
73.2%
33.3%
AX
More free cash flow
DOC
DOC
$271.6M more FCF
DOC
$357.0M
$85.4M
AX
Faster 2-yr revenue CAGR
AX
AX
Annualised
AX
14.3%
8.9%
DOC

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AX
AX
DOC
DOC
Revenue
$385.1M
$719.4M
Net Profit
$128.4M
$114.0M
Gross Margin
Operating Margin
45.6%
17.4%
Net Margin
33.3%
73.2%
Revenue YoY
25.1%
3.1%
Net Profit YoY
22.6%
2406.4%
EPS (diluted)
$2.22
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AX
AX
DOC
DOC
Q4 25
$385.1M
$719.4M
Q3 25
$323.4M
$705.9M
Q2 25
$321.4M
$694.3M
Q1 25
$308.8M
$702.9M
Q4 24
$307.9M
$698.0M
Q3 24
$320.7M
$700.4M
Q2 24
$290.9M
$695.5M
Q1 24
$294.8M
$606.6M
Net Profit
AX
AX
DOC
DOC
Q4 25
$128.4M
$114.0M
Q3 25
$112.4M
$-117.1M
Q2 25
$110.7M
$31.7M
Q1 25
$105.2M
$42.8M
Q4 24
$104.7M
$4.5M
Q3 24
$112.3M
$85.9M
Q2 24
$104.9M
$146.0M
Q1 24
$110.7M
$6.7M
Gross Margin
AX
AX
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
AX
AX
DOC
DOC
Q4 25
45.6%
17.4%
Q3 25
46.3%
9.2%
Q2 25
48.5%
5.7%
Q1 25
47.9%
7.7%
Q4 24
48.8%
-2.2%
Q3 24
49.6%
14.1%
Q2 24
49.6%
22.3%
Q1 24
52.8%
3.7%
Net Margin
AX
AX
DOC
DOC
Q4 25
33.3%
73.2%
Q3 25
34.7%
-16.6%
Q2 25
34.4%
4.6%
Q1 25
34.1%
6.1%
Q4 24
34.0%
0.7%
Q3 24
35.0%
12.3%
Q2 24
36.0%
21.0%
Q1 24
37.6%
1.1%
EPS (diluted)
AX
AX
DOC
DOC
Q4 25
$2.22
$0.16
Q3 25
$1.94
$-0.17
Q2 25
$1.89
$0.05
Q1 25
$1.81
$0.06
Q4 24
$1.80
$0.02
Q3 24
$1.93
$0.12
Q2 24
$1.75
$0.21
Q1 24
$1.91
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AX
AX
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$1.0B
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$2.9B
$7.5B
Total Assets
$28.2B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AX
AX
DOC
DOC
Q4 25
$1.0B
$467.5M
Q3 25
$2.6B
$91.0M
Q2 25
$1.9B
$89.4M
Q1 25
$2.0B
$70.6M
Q4 24
$2.4B
$119.8M
Q3 24
$2.6B
$180.4M
Q2 24
$2.0B
$106.9M
Q1 24
$2.1B
$101.8M
Total Debt
AX
AX
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$312.7M
$9.0B
Q1 25
$377.4M
$8.9B
Q4 24
$358.7M
$8.7B
Q3 24
$313.5M
$8.6B
Q2 24
$325.7M
$8.6B
Q1 24
$330.4M
$8.8B
Stockholders' Equity
AX
AX
DOC
DOC
Q4 25
$2.9B
$7.5B
Q3 25
$2.8B
$7.6B
Q2 25
$2.7B
$7.9B
Q1 25
$2.6B
$8.2B
Q4 24
$2.5B
$8.4B
Q3 24
$2.4B
$8.6B
Q2 24
$2.3B
$8.8B
Q1 24
$2.2B
$8.9B
Total Assets
AX
AX
DOC
DOC
Q4 25
$28.2B
$20.3B
Q3 25
$27.4B
$19.6B
Q2 25
$24.8B
$19.8B
Q1 25
$24.0B
$19.8B
Q4 24
$23.7B
$19.9B
Q3 24
$23.6B
$20.0B
Q2 24
$22.9B
$20.2B
Q1 24
$22.6B
$20.5B
Debt / Equity
AX
AX
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
0.12×
1.14×
Q1 25
0.14×
1.08×
Q4 24
0.14×
1.04×
Q3 24
0.13×
1.00×
Q2 24
0.14×
0.98×
Q1 24
0.15×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AX
AX
DOC
DOC
Operating Cash FlowLast quarter
$104.1M
$1.3B
Free Cash FlowOCF − Capex
$85.4M
$357.0M
FCF MarginFCF / Revenue
22.2%
49.6%
Capex IntensityCapex / Revenue
4.9%
124.4%
Cash ConversionOCF / Net Profit
0.81×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$695.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AX
AX
DOC
DOC
Q4 25
$104.1M
$1.3B
Q3 25
$118.4M
$315.0M
Q2 25
$490.3M
$363.5M
Q1 25
$73.7M
$279.4M
Q4 24
$162.5M
$1.1B
Q3 24
$70.8M
$318.2M
Q2 24
$305.5M
$316.2M
Q1 24
$115.8M
$152.6M
Free Cash Flow
AX
AX
DOC
DOC
Q4 25
$85.4M
$357.0M
Q3 25
$109.3M
Q2 25
$436.1M
Q1 25
$65.1M
Q4 24
$156.4M
$333.7M
Q3 24
$53.0M
Q2 24
$269.5M
Q1 24
$107.3M
FCF Margin
AX
AX
DOC
DOC
Q4 25
22.2%
49.6%
Q3 25
33.8%
Q2 25
135.7%
Q1 25
21.1%
Q4 24
50.8%
47.8%
Q3 24
16.5%
Q2 24
92.6%
Q1 24
36.4%
Capex Intensity
AX
AX
DOC
DOC
Q4 25
4.9%
124.4%
Q3 25
2.8%
Q2 25
16.9%
Q1 25
2.8%
Q4 24
2.0%
105.6%
Q3 24
5.5%
Q2 24
12.4%
Q1 24
2.9%
Cash Conversion
AX
AX
DOC
DOC
Q4 25
0.81×
10.99×
Q3 25
1.05×
Q2 25
4.43×
11.48×
Q1 25
0.70×
6.52×
Q4 24
1.55×
235.43×
Q3 24
0.63×
3.71×
Q2 24
2.91×
2.17×
Q1 24
1.05×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons